科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/02/08 | 3,515 | 3,522 | 3,467 | 3,497 | -14 | -0.4% | 153,800 |
| 2024/02/07 | 3,547 | 3,571 | 3,498 | 3,511 | -19 | -0.5% | 122,400 |
| 2024/02/06 | 3,501 | 3,543 | 3,496 | 3,530 | +29 | +0.8% | 101,300 |
| 2024/02/05 | 3,494 | 3,519 | 3,490 | 3,501 | +7 | +0.2% | 80,200 |
| 2024/02/02 | 3,501 | 3,510 | 3,491 | 3,494 | -6 | -0.2% | 67,400 |
| 2024/02/01 | 3,475 | 3,513 | 3,471 | 3,500 | +10 | +0.3% | 92,000 |
| 2024/01/31 | 3,477 | 3,492 | 3,442 | 3,490 | -1 | ±0% | 106,000 |
| 2024/01/30 | 3,515 | 3,515 | 3,488 | 3,491 | ±0 | ±0% | 64,400 |
| 2024/01/29 | 3,492 | 3,515 | 3,489 | 3,491 | -1 | ±0% | 61,300 |
| 2024/01/26 | 3,495 | 3,509 | 3,483 | 3,492 | -5 | -0.1% | 90,300 |
| 2024/01/25 | 3,468 | 3,497 | 3,465 | 3,497 | +18 | +0.5% | 57,500 |
| 2024/01/24 | 3,488 | 3,496 | 3,465 | 3,479 | -14 | -0.4% | 66,300 |
| 2024/01/23 | 3,496 | 3,518 | 3,490 | 3,493 | +3 | +0.1% | 84,900 |
| 2024/01/22 | 3,467 | 3,495 | 3,467 | 3,490 | +31 | +0.9% | 52,000 |
| 2024/01/19 | 3,478 | 3,488 | 3,456 | 3,459 | -28 | -0.8% | 108,700 |
| 2024/01/18 | 3,490 | 3,496 | 3,481 | 3,487 | -11 | -0.3% | 63,400 |
| 2024/01/17 | 3,524 | 3,534 | 3,493 | 3,498 | -3 | -0.1% | 91,500 |
| 2024/01/16 | 3,510 | 3,526 | 3,493 | 3,501 | -6 | -0.2% | 90,400 |
| 2024/01/15 | 3,480 | 3,510 | 3,478 | 3,507 | +27 | +0.8% | 87,400 |
| 2024/01/12 | 3,501 | 3,514 | 3,471 | 3,480 | -15 | -0.4% | 91,700 |
| 2024/01/11 | 3,510 | 3,513 | 3,476 | 3,495 | +2 | +0.1% | 112,900 |
| 2024/01/10 | 3,456 | 3,508 | 3,445 | 3,493 | +44 | +1.3% | 149,400 |
| 2024/01/09 | 3,394 | 3,452 | 3,394 | 3,449 | +55 | +1.6% | 180,400 |
| 2024/01/05 | 3,406 | 3,409 | 3,378 | 3,394 | -6 | -0.2% | 122,700 |
| 2024/01/04 | 3,350 | 3,405 | 3,326 | 3,400 | +45 | +1.3% | 129,500 |
| 2023/12/29 | 3,369 | 3,375 | 3,330 | 3,355 | +23 | +0.7% | 125,300 |
| 2023/12/28 | 3,299 | 3,334 | 3,291 | 3,332 | +33 | +1% | 66,900 |
| 2023/12/27 | 3,261 | 3,299 | 3,261 | 3,299 | +37 | +1.1% | 102,900 |
| 2023/12/26 | 3,252 | 3,279 | 3,252 | 3,262 | +12 | +0.4% | 76,000 |
| 2023/12/25 | 3,271 | 3,283 | 3,250 | 3,250 | -8 | -0.2% | 57,300 |
| 2023/12/22 | 3,218 | 3,258 | 3,218 | 3,258 | +47 | +1.5% | 101,000 |
| 2023/12/21 | 3,209 | 3,215 | 3,194 | 3,211 | -5 | -0.2% | 72,400 |
| 2023/12/20 | 3,208 | 3,224 | 3,196 | 3,216 | +24 | +0.8% | 136,800 |
| 2023/12/19 | 3,196 | 3,206 | 3,183 | 3,192 | +3 | +0.1% | 118,900 |
| 2023/12/18 | 3,172 | 3,193 | 3,161 | 3,189 | -2 | -0.1% | 121,800 |
| 2023/12/15 | 3,233 | 3,233 | 3,175 | 3,191 | -43 | -1.3% | 231,600 |
| 2023/12/14 | 3,262 | 3,270 | 3,222 | 3,234 | -19 | -0.6% | 90,100 |
| 2023/12/13 | 3,249 | 3,264 | 3,233 | 3,253 | -11 | -0.3% | 117,000 |
| 2023/12/12 | 3,293 | 3,293 | 3,259 | 3,264 | -9 | -0.3% | 104,800 |
| 2023/12/11 | 3,273 | 3,292 | 3,258 | 3,273 | ±0 | ±0% | 85,900 |
| 2023/12/08 | 3,314 | 3,319 | 3,267 | 3,273 | -35 | -1.1% | 116,800 |
| 2023/12/07 | 3,331 | 3,336 | 3,299 | 3,308 | -29 | -0.9% | 107,600 |
| 2023/12/06 | 3,324 | 3,344 | 3,315 | 3,337 | +7 | +0.2% | 104,900 |
| 2023/12/05 | 3,350 | 3,357 | 3,323 | 3,330 | -8 | -0.2% | 80,200 |
| 2023/12/04 | 3,369 | 3,369 | 3,327 | 3,338 | -53 | -1.6% | 105,100 |
| 2023/12/01 | 3,391 | 3,406 | 3,375 | 3,391 | +13 | +0.4% | 95,100 |
| 2023/11/30 | 3,337 | 3,378 | 3,335 | 3,378 | +35 | +1% | 145,300 |
| 2023/11/29 | 3,346 | 3,367 | 3,343 | 3,343 | -3 | -0.1% | 105,800 |
| 2023/11/28 | 3,326 | 3,347 | 3,323 | 3,346 | +20 | +0.6% | 98,900 |
| 2023/11/27 | 3,333 | 3,344 | 3,320 | 3,326 | ±0 | ±0% | 70,100 |
301～
350
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 229,900円 | - | - | 0.00% | - | 106.48倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
